ХэлEnglishFrançaisالعربيةEspañolPortuguêsРусскийУкраїнськаTürkçeفارسیاردوবাংলাहिन्दीKiswahiliአማርኛनेपालीසිංහලSrpskiO'zbekchaМонгол

Wolters Kluwer (Lippincott)

A major medical publisher without a standalone country-based waiver. Authors in low-income countries without an institutional Read & Publish agreement pay the full APC. This is a critical gap: an author in Ethiopia publishing in a Lippincott OA journal pays full price unless their institution has an R&P deal.

Хэвлэгчийн бодлогыг шалгасан 20 August 2026

ClassificationResearch4Life eligibility criteria
Scale200+ medical journals (Lippincott brand), predominantly hybrid
APC range$1,050–$3,950
Which author countsCorresponding author at participating institution
HybridNot stated
How it is appliedInstitutional R&P agreements only; no standalone country-based waiver published

Зохиогчдод энэ юу гэсэн үг вэ

A major medical publisher without a standalone country-based waiver. Authors in low-income countries without an institutional Read & Publish agreement pay the full APC. This is a critical gap: an author in Ethiopia publishing in a Lippincott OA journal pays full price unless their institution has an R&P deal.

Улсаа шалгах

Та төлбөр чөлөөлөлт эсвэл хөнгөлөлт авах эрхтэй юу? Улсаа оруулна уу.

УЛСААР ЧӨЛӨӨЛӨЛТ →

Энэ хуудасны эх сурвалж

Бодлого
Wolters Kluwer (Lippincott) — waiver / APC policy
Alt
Wolters Kluwer (Lippincott) — additional policy page
шалгасан
20 August 2026